Emitents | Olainfarm, AS (213800WCG52W62ENOP27) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Veids | Citi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Valoda | EN | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statuss | Publicēts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Versija | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Datums | 2011-05-11 20:36:53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Versijas komentārs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teksts |
Olaine, May 11, 2011
Sales of “Olainfarm” grew by 65% in
April
Preliminary sales figures of AS “Olainfarm” for April
2011 show that sales have grown by 65% compared to April 2010 and
have reached 3.38 million lats (4.81 million Euro). The most rapid
sales growth was achieved in Kazakhstan (by 157%), Azerbaijan (by
153%), Ukraine (by 133%) and Tajikistan (by 126%). The main
sales markets of AS “Olainfarm” during April 2011 were Russia,
Ukraine, UK, Kazakhstan, Belarus and Latvia.
According to preliminary results, during 4 months of
2011 the sales have reached 11.32 million lats (16.11 million
Euro), which represents an increase by 39% compared to the first
four months of 2010. The biggest sales increases were observed
in Canada, where sales have increased more than 30 times, in
Bulgaria (by 277%), UK (by 100%), Ukraine (by 95%), Italy (by 89%)
and Latvia (by 60%). Major sales markets of AS “Olainfarm” during
four months of 2011 were Russia, Ukraine, Belarus, UK and
Latvia.
Operating plan and budget of AS “Olainfarm” for 2011
provides that company plans the sales of 29.4 million lats (41.8
million Euro) and the net profit of 5.1 million lats (7.3 million
Euro).
A/s Olainfarm is one of the biggest pharmaceutical
companies in Latvia with nearly 40 years of experience in
production of medication and chemical and pharmaceutical products.
A basic principle of company's operations is to produce reliable
and effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
30 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information
prepared by:
Salvis Lapins Member of the Board A/s „Olainfarm” Tel: +371 6 7013 717 Cell: +371 2 6448 873 E-mail: slapinsh@olainfarm |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pielikumi |
|